Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism MCT1 inhibitors(Monocarboxylate transporter 1 inhibitors), SLC16A4 modulators(solute carrier family 16 member 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 07 Nov 2022 |